Novartis and Google team up to commercialize 'smart' contact lenses

Novartis ($NVS) has struck a deal with Google ($GOOG) to develop contact lens technology. The deal gives Google a partner with healthcare experience to commercialize the glucose-recording contact lens technology it unveiled earlier this year. Novartis hopes to have a product based on the technology on the market within 5 years. Reuters article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.